(Adnkronos) - “È importantissimo che i pazienti possano accedere ai farmaci prescritti dal medico dopo aver valutato le condizioni della persona. È altrettanto importante che l'accesso sia precoce e che sia equo in tutte le Regioni”. Lo afferma Antonella Celano, presidente Apmarr, Associazione nazionale persone con malattie reumatologiche e rare, a margine dell’evento con cui si è annunciato il via libera di Aifa all’estensione della rimborsabilità in Italia di bimekizumab per l’artrite psoriasica attiva, dopo quella ottenuta nel marzo 2023 per la psoriasi a placche da moderata a severa.
Category
🗞
NewsTranscript
00:00What is the role of information in the treatment of a pathology?
00:04Information is everything in the treatment of a pathology.
00:09Information is what allows you to be adherent to therapy,
00:13it is what allows you to know the lifestyles to live,
00:17it is what allows you to be able to perceive if something is wrong in your body.
00:23In short, communication passes through medical-patient communication
00:28and it is absolutely essential in the treatment of a chronic pathology.
00:32It is very important that patients can access all the drugs that the doctor has available.
00:39If the doctor prescribes a drug to a patient in particular,
00:44it is because he has evaluated the conditions and therefore obviously
00:48considers that this is the drug suitable for that person.
00:51Therefore, nowadays it is possible to treat,
00:55according to the peculiarities of the pathology in a particular patient
01:00and the peculiarities of the patient himself.
01:03So it is important that access is early, that access is equitable in all regions,
01:09because today, unfortunately, in our country,
01:12very often people do not access drugs equally.
01:18Even today we still have access difficulties between ASL and DASL in the same region,
01:24because there are a whole series of obstacles that prevent the person
01:32from being able to arrive at an early treatment with the right drug.
01:37So we would like health not to be considered a cost,
01:41but to be considered an investment,
01:44because we invest in the health of the citizens,
01:47and above all the citizen in good health with a well-treated pathology
01:51also becomes a resource because it carries pills.
01:54And so, of course, we are also concerned about this.